Within the context of the AD brain, low‐dose IL‐2 secretion has been described to downregulate pro‐inflammatory signaling,64 prevent prolonged pro‐inflammatory damage,47 prevent synaptic failure, and improve memory in mice.65 The gene discussed is IL2; the disease is Alzheimer disease.